Page last updated: 2024-08-22

n-methylaspartate and Cerebral Hemorrhage

n-methylaspartate has been researched along with Cerebral Hemorrhage in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chow, N; Davis, TP; Guo, H; Singh, I; Thiyagarajan, M; Wang, Y; Zlokovic, BV	1
Hartmann, A; Mohr, JP	1

Other Studies

2 other study(ies) available for n-methylaspartate and Cerebral Hemorrhage

Article	Year
Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. Stroke, 2009, Volume: 40, Issue:5 Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Hemorrhage; Endothelial Cells; Excitatory Amino Acid Agonists; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Mutation; N-Acetylneuraminic Acid; N-Methylaspartate; Neurons; Neuroprotective Agents; Partial Thromboplastin Time; Polysaccharides; Pregnancy; Protein C; Recombinant Proteins; Risk	2009
Treatment of acute ischemic stroke: where are we? Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:1 Topics: Animals; Aspirin; Brain Damage, Chronic; Brain Ischemia; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebrovascular Circulation; Clinical Trials as Topic; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; N-Methylaspartate; Neuroprotective Agents; Platelet Aggregation Inhibitors; Reperfusion Injury; Rodentia; Thrombolytic Therapy; Warfarin	1999

Article

Year

Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity.

Stroke, 2009, Volume: 40, Issue:5

Topics: Animals; Apoptosis; Cells, Cultured; Cerebral Hemorrhage; Endothelial Cells; Excitatory Amino Acid Agonists; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Mutation; N-Acetylneuraminic Acid; N-Methylaspartate; Neurons; Neuroprotective Agents; Partial Thromboplastin Time; Polysaccharides; Pregnancy; Protein C; Recombinant Proteins; Risk

2009

Treatment of acute ischemic stroke: where are we?

Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:1

Topics: Animals; Aspirin; Brain Damage, Chronic; Brain Ischemia; Calcium Channel Blockers; Cerebral Hemorrhage; Cerebrovascular Circulation; Clinical Trials as Topic; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; N-Methylaspartate; Neuroprotective Agents; Platelet Aggregation Inhibitors; Reperfusion Injury; Rodentia; Thrombolytic Therapy; Warfarin

1999